CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Middle East Pharmactl&Chem Inds&Med PSC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Middle East Pharmactl&Chem Inds&Med PSC
Midpharma Building
Jarash Highway, Mobes, Al Baqaa Area,
Phone: +962 64794444p:+962 64794444 AMMAN, 11821  Jordan Fax: +962 64725154f:+962 64725154

Business Summary
Middle East Pharmaceutical and Chemical Industries and Medical Appliances Company PSC (Midpharma) is a Jordan-based company engaged in the pharmaceutical sector. The Company’s activities include manufacturing, production and distribution of pharmaceuticals, medicines and chemicals related to the pharmaceuticals industry. The Company's main products include antibiotics, antihypertensive, anti-diabetics, anti-ulcerants, antifungal, hypolipidemics, analgesics, antipyretics, multivitamins and minerals supplements, alpha-blockers, erectile dysfunction treatment and anti-anemic products. In addition, the Company also focuses on the establishment and operation of a Centre for Pharmaceutical Research and Therapeutic. As of December 31, 2011, the Company had a wholly owned subsidiary, Middle East Pharmaceutical, Algeria.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer and Chairman of the Board, representing Tantash Group for Investment Co. Mazen H.Tantash 38
Vice Chairman of the Board, representing Arab Center for Pharmaceuticals & Chemicals Industries Samer S.Jawdat 49 2/25/2010 2/25/2010
Finance and Administration Manager NabilSalameh 5/26/2013 5/26/2013
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Middle East Pharmaceutical & Chemical
Middle East Pharmaceutical & Chemical In
MPHA

General Information
Number of Employees: 294 (As of 12/31/2012)
Outstanding Shares: 9,869,583 (As of 3/31/2019)
Stock Exchange: AFM
Fax Number: +962 64725154


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023